Cargando…

Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice

Influenza and S. pneumoniae infections are a significant cause of morbidity and mortality worldwide. Intranasal live influenza vaccine (LAIV) may prevent influenza-related bacterial complications. The objectives of the study are to estimate resistance against early influenza infection and post-influ...

Descripción completa

Detalles Bibliográficos
Autores principales: Desheva, Yulia, Leontieva, Galina, Kramskaya, Tatiana, Losev, Igor, Rekstin, Andrey, Petkova, Nadezhda, Kudar, Polina, Suvorov, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228789/
https://www.ncbi.nlm.nih.gov/pubmed/35744668
http://dx.doi.org/10.3390/microorganisms10061150
_version_ 1784734567479902208
author Desheva, Yulia
Leontieva, Galina
Kramskaya, Tatiana
Losev, Igor
Rekstin, Andrey
Petkova, Nadezhda
Kudar, Polina
Suvorov, Alexander
author_facet Desheva, Yulia
Leontieva, Galina
Kramskaya, Tatiana
Losev, Igor
Rekstin, Andrey
Petkova, Nadezhda
Kudar, Polina
Suvorov, Alexander
author_sort Desheva, Yulia
collection PubMed
description Influenza and S. pneumoniae infections are a significant cause of morbidity and mortality worldwide. Intranasal live influenza vaccine (LAIV) may prevent influenza-related bacterial complications. The objectives of the study are to estimate resistance against early influenza infection and post-influenza pneumococcal pneumonia after LAIV in mice. Mice were administered intranasally the monovalent LAIV A/17/Mallard Netherlands/00/95(H7N3), A/17/South Africa/2013/01(H1N1)pdm09 or trivalent LAIV 2017–2018 years of formulation containing A/17/New York/15/5364(H1N1)pdm09 vaccine strain. LAIV demonstrated early protection against homologous and heterologous infections with A/South Africa/3626/2013 (H1N1) pdm09 influenza virus on day six, following immunization. Following boost immunization, trivalent LAIV demonstrated a pronounced protective effect both in terms of lethality and pneumococcal lung infection when S. pneumoniae infection was performed three days after the onset of influenza infection. Conclusion: LAIV provides early protection against homologous and heterologous viral infections and has a protective effect against post-influenza pneumococcal infection. These data suggest that the intranasal administration of LAIV may be useful during the cycle of circulation not only of influenza viruses, but also of other causative agents of acute respiratory infections.
format Online
Article
Text
id pubmed-9228789
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92287892022-06-25 Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice Desheva, Yulia Leontieva, Galina Kramskaya, Tatiana Losev, Igor Rekstin, Andrey Petkova, Nadezhda Kudar, Polina Suvorov, Alexander Microorganisms Article Influenza and S. pneumoniae infections are a significant cause of morbidity and mortality worldwide. Intranasal live influenza vaccine (LAIV) may prevent influenza-related bacterial complications. The objectives of the study are to estimate resistance against early influenza infection and post-influenza pneumococcal pneumonia after LAIV in mice. Mice were administered intranasally the monovalent LAIV A/17/Mallard Netherlands/00/95(H7N3), A/17/South Africa/2013/01(H1N1)pdm09 or trivalent LAIV 2017–2018 years of formulation containing A/17/New York/15/5364(H1N1)pdm09 vaccine strain. LAIV demonstrated early protection against homologous and heterologous infections with A/South Africa/3626/2013 (H1N1) pdm09 influenza virus on day six, following immunization. Following boost immunization, trivalent LAIV demonstrated a pronounced protective effect both in terms of lethality and pneumococcal lung infection when S. pneumoniae infection was performed three days after the onset of influenza infection. Conclusion: LAIV provides early protection against homologous and heterologous viral infections and has a protective effect against post-influenza pneumococcal infection. These data suggest that the intranasal administration of LAIV may be useful during the cycle of circulation not only of influenza viruses, but also of other causative agents of acute respiratory infections. MDPI 2022-06-02 /pmc/articles/PMC9228789/ /pubmed/35744668 http://dx.doi.org/10.3390/microorganisms10061150 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Desheva, Yulia
Leontieva, Galina
Kramskaya, Tatiana
Losev, Igor
Rekstin, Andrey
Petkova, Nadezhda
Kudar, Polina
Suvorov, Alexander
Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice
title Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice
title_full Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice
title_fullStr Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice
title_full_unstemmed Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice
title_short Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice
title_sort live influenza vaccine provides early protection against homologous and heterologous influenza and may prevent post-influenza pneumococcal infections in mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228789/
https://www.ncbi.nlm.nih.gov/pubmed/35744668
http://dx.doi.org/10.3390/microorganisms10061150
work_keys_str_mv AT deshevayulia liveinfluenzavaccineprovidesearlyprotectionagainsthomologousandheterologousinfluenzaandmaypreventpostinfluenzapneumococcalinfectionsinmice
AT leontievagalina liveinfluenzavaccineprovidesearlyprotectionagainsthomologousandheterologousinfluenzaandmaypreventpostinfluenzapneumococcalinfectionsinmice
AT kramskayatatiana liveinfluenzavaccineprovidesearlyprotectionagainsthomologousandheterologousinfluenzaandmaypreventpostinfluenzapneumococcalinfectionsinmice
AT losevigor liveinfluenzavaccineprovidesearlyprotectionagainsthomologousandheterologousinfluenzaandmaypreventpostinfluenzapneumococcalinfectionsinmice
AT rekstinandrey liveinfluenzavaccineprovidesearlyprotectionagainsthomologousandheterologousinfluenzaandmaypreventpostinfluenzapneumococcalinfectionsinmice
AT petkovanadezhda liveinfluenzavaccineprovidesearlyprotectionagainsthomologousandheterologousinfluenzaandmaypreventpostinfluenzapneumococcalinfectionsinmice
AT kudarpolina liveinfluenzavaccineprovidesearlyprotectionagainsthomologousandheterologousinfluenzaandmaypreventpostinfluenzapneumococcalinfectionsinmice
AT suvorovalexander liveinfluenzavaccineprovidesearlyprotectionagainsthomologousandheterologousinfluenzaandmaypreventpostinfluenzapneumococcalinfectionsinmice